Hims & Hers: $3B valuation, IPO Readiness 58, Public. Direct-to-consumer telehealth brand offering treatment for hair loss, ED, mental health, and more. Track live on The IPO Stack.
Direct-to-consumer telehealth brand offering treatment for hair loss, ED, mental health, and more.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Hims & Hers IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Hims & Hers is already a public company.
Hims & Hers is valued at $3B as of May 2019. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Hims & Hers is already a public company. You can invest by purchasing shares on public stock exchanges.
Hims & Hers scores 58/100 (Grade: C) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Hims & Hers has raised $197M in total venture capital and private equity funding, with backing from Goldman Sachs, Forerunner Ventures, Redpoint Ventures.
Hims & Hers's notable investors include Goldman Sachs, Forerunner Ventures, Redpoint Ventures, IVP. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Hims & Hers is a Healthcare Technology company. Direct-to-consumer telehealth brand offering treatment for hair loss, ED, mental health, and more.